Trial Profile
Second phase Ib trial of PUR 118 in patients with chronic obstructive pulmonary disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2012
Price :
$35
*
At a glance
- Drugs PUR 118 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Pulmatrix
- 18 Sep 2012 New trial record